Read the insights

Get the full findings

The pharmaceuticals and biotechnology sector is in a uniquely challenging situation. Having previously relied on mergers and acquisitions to fill portfolio gaps, fuel innovation and drive growth, a changing landscape means proposed M&As are under heavy scrutiny.

This highlights a new opportunity for pharmaceutical and biotech firms: to refocus on driving growth from the inside.


Three internal opportunities for the health sector

1. Create a purpose "with teeth"

A “purpose with teeth” will help businesses to stand out and attract the like-minded talent and partners they need to grow.

2. Elevate and revitalize the corporate brand

After years of M&A, pharmaceutical and biotech firms have lost sight of the potential of their corporate brand – it's time to bring it back.

3. Close the M&A culture gap

Build a unified culture where everyone is pulling in the same direction through a shared purpose.


Read the full findings here >